Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sphingosine-1-phosphate
100%
Glioblastoma Cells
100%
Cell Invasiveness
100%
Urokinase-type Plasminogen Activator
50%
Glioblastoma multiforme Cells
41%
Sphingosine-1-phosphate Receptor (S1PR)
25%
Overexpression
16%
Glioblastoma multiforme
16%
Invasiveness
16%
Cell Invasion
16%
Glioma Cells
16%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
16%
Patient Prognosis
16%
Survival Time
8%
Receptor-mediated
8%
High-level Expression
8%
Expression Level
8%
Receptor Signaling
8%
Neutralizing Antibodies
8%
Induced Expression
8%
Basal Expression
8%
Matricellular Proteins
8%
Bioactive Lipids
8%
Sphingosine Kinase 1 (SphK1)
8%
Invasion Assay
8%
Basal Activity
8%
Brain Neoplasms
8%
Medicine and Dentistry
Glioblastoma
100%
Cell Invasion
100%
Sphingosine 1 Phosphate
100%
Urokinase
100%
Receptor
16%
Glioma Cell
16%
Malignant Neoplasm
8%
In Vitro
8%
Neutralizing Antibody
8%
Survival Time
8%
Intracranial Tumor
8%
Sphingosine Kinase 1
8%
Neuroscience
Sphingosine 1 Phosphate
100%
Urokinase
100%
Cell Invasion
100%
Glioblastoma Multiforme
58%
Sphingosine-1-Phosphate Receptor
25%
Receptor
16%
In Vitro
8%
Neutralizing Antibody
8%
Intracranial Tumor
8%
Sphingosine Kinase 1
8%
Biochemistry, Genetics and Molecular Biology
Sphingosine-1-Phosphate
100%
Cell Invasion
100%
Urokinase
100%
Sphingosine-1-Phosphate Receptor
25%
Tumor Spheroid
16%
Enzyme
8%
Neutralizing Antibody
8%
Survival Time
8%
Matricellular Protein
8%
Bioactive Lipids
8%
Sphingosine Kinase 1
8%